
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A novel anti-LAG-3/TIGIT bispecific antibody exhibits potent anti-tumor efficacy in mouse models as monotherapy or in combination with PD-1 antibody
Tongcheng Dai, Hao Sun, Tyler Liban, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Tongcheng Dai, Hao Sun, Tyler Liban, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Showing 4 citing articles:
Mechanisms, combination therapy, and biomarkers in cancer immunotherapy resistance
Manshi Yang, Mengying Cui, Yang Sun, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Manshi Yang, Mengying Cui, Yang Sun, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Targeting novel regulated cell death: disulfidptosis in cancer immunotherapy with immune checkpoint inhibitors
Fei Du, Guojun Wang, Qian Dai, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Fei Du, Guojun Wang, Qian Dai, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Deciphering LAG-3: unveiling molecular mechanisms and clinical advancements
Alejandra Martínez‐Pérez, Rocío Granda‐Díaz, Candelaria Aguilar-García, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Alejandra Martínez‐Pérez, Rocío Granda‐Díaz, Candelaria Aguilar-García, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Turning Cancer Immunotherapy to the Emerging Immune Checkpoint TIGIT: Will This Break Through the Limitations of the Legacy Approach?
Haozhe Cui, Eyad Elkord
Vaccines (2024) Vol. 12, Iss. 12, pp. 1306-1306
Open Access
Haozhe Cui, Eyad Elkord
Vaccines (2024) Vol. 12, Iss. 12, pp. 1306-1306
Open Access